Cargando…

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma

Detalles Bibliográficos
Autores principales: de Martimprey, Henri, Bertrand, Jean-Remi, Fusco, Alfredo, Santoro, Massimo, Couvreur, Patrick, Vauthier, Christine, Malvy, Claude
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588511/
http://dx.doi.org/10.1093/nar/gkn882
_version_ 1782160942001291264
author de Martimprey, Henri
Bertrand, Jean-Remi
Fusco, Alfredo
Santoro, Massimo
Couvreur, Patrick
Vauthier, Christine
Malvy, Claude
author_facet de Martimprey, Henri
Bertrand, Jean-Remi
Fusco, Alfredo
Santoro, Massimo
Couvreur, Patrick
Vauthier, Christine
Malvy, Claude
author_sort de Martimprey, Henri
collection PubMed
description
format Text
id pubmed-2588511
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-25885112009-03-04 siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma de Martimprey, Henri Bertrand, Jean-Remi Fusco, Alfredo Santoro, Massimo Couvreur, Patrick Vauthier, Christine Malvy, Claude Nucleic Acids Res Corrigendum Oxford University Press 2008-12 2008-11-25 /pmc/articles/PMC2588511/ http://dx.doi.org/10.1093/nar/gkn882 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Corrigendum
de Martimprey, Henri
Bertrand, Jean-Remi
Fusco, Alfredo
Santoro, Massimo
Couvreur, Patrick
Vauthier, Christine
Malvy, Claude
siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
title siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
title_full siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
title_fullStr siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
title_full_unstemmed siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
title_short siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
title_sort sirna nanoformulation against the ret/ptc1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
topic Corrigendum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588511/
http://dx.doi.org/10.1093/nar/gkn882
work_keys_str_mv AT demartimpreyhenri sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma
AT bertrandjeanremi sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma
AT fuscoalfredo sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma
AT santoromassimo sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma
AT couvreurpatrick sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma
AT vauthierchristine sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma
AT malvyclaude sirnananoformulationagainsttheretptc1junctiononcogeneisefficientinaninvivomodelofpapillarythyroidcarcinoma